South Korea Duodenal Ulcer Treatment Market Size & Outlook
Related Markets
South Korea duodenal ulcer treatment market highlights
- The South Korea duodenal ulcer treatment market generated a revenue of USD 65.2 million in 2024 and is expected to reach USD 84.6 million by 2030.
- The South Korea market is expected to grow at a CAGR of 4.4% from 2025 to 2030.
- In terms of segment, proton pump inhibitors was the largest revenue generating treatment in 2024.
- Antibiotics is the most lucrative treatment segment registering the fastest growth during the forecast period.
Duodenal ulcer treatment market data book summary
| Market revenue in 2024 | USD 65.2 million |
| Market revenue in 2030 | USD 84.6 million |
| Growth rate | 4.4% (CAGR from 2025 to 2030) |
| Largest segment | Proton pump inhibitors |
| Fastest growing segment | Antibiotics |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Proton Pump Inhibitors, H2 Antagonists, Antibiotics, Other |
| Key market players worldwide | GSK PLC, Pfizer Inc, Abbott Laboratories, Merck KGaA, Novartis AG ADR, Bristol-Myers Squibb Co, AstraZeneca PLC, Takeda Pharmaceutical Co Ltd, Eisai Co Ltd |
Other key industry trends
- In terms of revenue, South Korea accounted for 1.4% of the global duodenal ulcer treatment market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China duodenal ulcer treatment market is projected to lead the regional market in terms of revenue in 2030.
- South Korea is the fastest growing regional market in Asia Pacific and is projected to reach USD 84.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Duodenal Ulcer Treatment Market Scope
Duodenal Ulcer Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Eisai Co Ltd | View profile | 11076 | 4-6-10 Koishikawa, Bunkyo-ku, Tokyo, Japan, 112-8088 | http://www.eisai.co.jp |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
South Korea duodenal ulcer treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to duodenal ulcer treatment market will help companies and investors design strategic landscapes.
Proton pump inhibitors was the largest segment with a revenue share of 54.29% in 2024. Horizon Databook has segmented the South Korea duodenal ulcer treatment market based on proton pump inhibitors, h2 antagonists, antibiotics, other covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to South Korea duodenal ulcer treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea duodenal ulcer treatment market databook
-
Our clientele includes a mix of duodenal ulcer treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea duodenal ulcer treatment market , including forecasts for subscribers. This country databook contains high-level insights into South Korea duodenal ulcer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea duodenal ulcer treatment market size, by treatment, 2018-2030 (US$M)
South Korea Duodenal Ulcer Treatment Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
